Zenith Drugs Limited (NSE:ZENITHDRUG)
India · Delayed Price · Currency is INR 42.65
-1.35 (-3.07%)
Aug 21, 2026, 3:29 PM IST
Zenith Drugs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 2.61 | 2.63 | 87.43 | 2.79 | 30.01 |
Cash & Short-Term Investments | 2.61 | 2.63 | 87.43 | 2.79 | 30.01 |
Cash Growth | -0.72% | -96.99% | 3032.53% | -90.70% | 62.37% |
Accounts Receivable | 733.55 | 605.77 | 673.95 | 493.11 | 320.68 |
Other Receivables | - | - | - | - | 0.68 |
Receivables | 862.81 | 607.95 | 676.32 | 496.32 | 321.36 |
Inventory | 424.22 | 396.12 | 257.58 | 236.73 | 121.31 |
Prepaid Expenses | - | - | - | - | 3.37 |
Other Current Assets | - | 145.06 | 107.02 | 103.38 | 59.25 |
Total Current Assets | 1,290 | 1,152 | 1,128 | 839.22 | 535.3 |
Property, Plant & Equipment | 468.8 | 431.86 | 148.42 | 116.98 | 131.23 |
Long-Term Investments | - | - | 0.26 | - | - |
Other Intangible Assets | 41.72 | 1.76 | 0.07 | 0.1 | 0.12 |
Long-Term Deferred Tax Assets | 1.75 | 0.12 | 0.66 | - | - |
Other Long-Term Assets | 73.29 | 29.27 | 23.76 | 0 | 19.2 |
Total Assets | 1,875 | 1,615 | 1,342 | 979.25 | 685.85 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 555.89 | 401.84 | 426.31 | 508.74 | 346.81 |
Accrued Expenses | - | 8.1 | 5.17 | 11.28 | 10.7 |
Short-Term Debt | 349.91 | 301.92 | 140.06 | 157.89 | 40.57 |
Current Portion of Long-Term Debt | - | 55.81 | 20.74 | 19.6 | 51.81 |
Current Income Taxes Payable | - | 23.73 | 38.5 | 17.58 | 13.34 |
Other Current Liabilities | 19 | 1.64 | 10.22 | 1.45 | 2.55 |
Total Current Liabilities | 924.79 | 793.03 | 641 | 716.54 | 465.78 |
Long-Term Debt | 201.15 | 127.96 | 78.53 | 83.63 | 95.71 |
Pension & Post-Retirement Benefits | - | - | - | - | 0.67 |
Long-Term Deferred Tax Liabilities | - | - | - | 1.72 | 2.63 |
Total Liabilities | 1,126 | 920.98 | 719.53 | 801.89 | 564.79 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 171.49 | 171.49 | 171.49 | 4 | 4 |
Additional Paid-In Capital | - | 306.58 | 306.58 | 2 | 2 |
Retained Earnings | - | 215.72 | 144.11 | 171.22 | 114.91 |
Comprehensive Income & Other | 577.77 | -0 | - | - | - |
Total Common Equity | 749.26 | 693.79 | 622.19 | 177.22 | 120.91 |
Minority Interest | - | - | - | 0.15 | 0.15 |
Shareholders' Equity | 749.26 | 693.79 | 622.19 | 177.36 | 121.06 |
Total Liabilities & Equity | 1,875 | 1,615 | 1,342 | 979.25 | 685.85 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 551.05 | 485.68 | 239.33 | 261.12 | 188.09 |
Net Cash (Debt) | -548.44 | -483.05 | -151.9 | -258.33 | -158.08 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -31.99 | -28.17 | -8.86 | -21.53 | -13.17 |
Filing Date Shares Outstanding | 17.11 | 17.15 | 17.15 | 12 | 12 |
Total Common Shares Outstanding | 17.11 | 17.15 | 17.15 | 12 | 12 |
Working Capital | 364.85 | 358.74 | 487.35 | 122.68 | 69.52 |
Book Value Per Share | 43.79 | 40.46 | 36.28 | 14.77 | 10.08 |
Tangible Book Value | 707.54 | 692.03 | 622.11 | 177.12 | 120.79 |
Tangible Book Value Per Share | 41.35 | 40.35 | 36.28 | 14.76 | 10.07 |
Land | - | 33.27 | 33.27 | - | 27.47 |
Buildings | - | 180.57 | 53.04 | - | 52.8 |
Machinery | - | 305.94 | 112.34 | - | 87.45 |
Construction In Progress | - | 31.02 | 39.07 | - | 26.62 |